Use of real-world data to study health services utilisation and comorbidities in long-term breast cancer survivors (the SURBCAN study): study protocol for a longitudinal population-based cohort study
Jansana, A. ; Del Cura, I. ; Prados-Torres, A. ; Sanz Cuesta, T. ; Poblador-Plou, B. ; Gimeno Miguel, A. ; Lanzuela, M. ; Ibañez, B. ; Tamayo, I. ; Moreno-Iribas, C. ; Padilla-Ruiz, M. ; Redondo, M. ; Comas, M. ; Domingo, L. ; Díaz-Holgado, A. ; Salamanca, F.J. ; Castells, X. ; Sala, M. ; SURBCAN, group
Resumen: INTRODUCTION: Breast cancer has become a chronic disease due to survival improvement and the need to monitor the side effects of treatment and the disease itself. The aim of the SURBCAN study is to describe comorbidity, healthcare services use and adherence to preventive recommendations in long-term breast cancer survivors and to compare them with those in women without this diagnosis in order to improve and adapt the care response to this group of survivors.
METHODS AND ANALYSIS: Population-based retrospective cohort study using real-world data from cancer registries and linked electronic medical records in five Spanish regions. Long-term breast cancer survivors diagnosed between 2000 and 2006 will be identified and matched by age and administrative health area with women without this diagnosis. Sociodemographic and clinical variables including comorbidities and variables on the use of health services between 2012 and 2016 will be obtained from databases in primary and hospital care. Health services use will be assessed through the annual number of visits to primary care professionals and to specialists and through annual imaging and laboratory tests. Factors associated with healthcare utilisation and comorbidities will be analysed using multilevel logistic regression models. Recruitment started in December 2018.
ETHICS AND DISSEMINATION: This study was approved by the Ethics Committee of Parc de Salut Mar. The results of the study will be published in a peer-reviewed journal and will be presented at national and international scientific conferences and at patient associations.
TRIAL REGISTRATION NUMBER: This protocol is registered in Clinical Trials.gov (identifier: NCT03846999).
Idioma: Inglés
DOI: 10.1136/bmjopen-2020-040253
Año: 2020
Publicado en: BMJ open 10, 9 (2020), e040253 [7 pp]
ISSN: 2044-6055
Factor impacto JCR: 2.692 (2020)
Categ. JCR: MEDICINE, GENERAL & INTERNAL rank: 64 / 169 = 0.379 (2020) - Q2 - T2
Factor impacto SCIMAGO: 1.131 - Medicine (miscellaneous) (Q1)
Financiación: info:eu-repo/grantAgreement/ES/ISCIII/PI15-00098
Financiación: info:eu-repo/grantAgreement/ES/ISCIII/PI16-00244
Financiación: info:eu-repo/grantAgreement/ES/REDISSEC/RD16-0001-0013
Tipo y forma: Article (Published version)
You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. You may not use the material for commercial purposes.
Exportado de SIDERAL (2021-09-02-09:54:57)
Visitas y descargas
METHODS AND ANALYSIS: Population-based retrospective cohort study using real-world data from cancer registries and linked electronic medical records in five Spanish regions. Long-term breast cancer survivors diagnosed between 2000 and 2006 will be identified and matched by age and administrative health area with women without this diagnosis. Sociodemographic and clinical variables including comorbidities and variables on the use of health services between 2012 and 2016 will be obtained from databases in primary and hospital care. Health services use will be assessed through the annual number of visits to primary care professionals and to specialists and through annual imaging and laboratory tests. Factors associated with healthcare utilisation and comorbidities will be analysed using multilevel logistic regression models. Recruitment started in December 2018.
ETHICS AND DISSEMINATION: This study was approved by the Ethics Committee of Parc de Salut Mar. The results of the study will be published in a peer-reviewed journal and will be presented at national and international scientific conferences and at patient associations.
TRIAL REGISTRATION NUMBER: This protocol is registered in Clinical Trials.gov (identifier: NCT03846999).
Idioma: Inglés
DOI: 10.1136/bmjopen-2020-040253
Año: 2020
Publicado en: BMJ open 10, 9 (2020), e040253 [7 pp]
ISSN: 2044-6055
Factor impacto JCR: 2.692 (2020)
Categ. JCR: MEDICINE, GENERAL & INTERNAL rank: 64 / 169 = 0.379 (2020) - Q2 - T2
Factor impacto SCIMAGO: 1.131 - Medicine (miscellaneous) (Q1)
Financiación: info:eu-repo/grantAgreement/ES/ISCIII/PI15-00098
Financiación: info:eu-repo/grantAgreement/ES/ISCIII/PI16-00244
Financiación: info:eu-repo/grantAgreement/ES/REDISSEC/RD16-0001-0013
Tipo y forma: Article (Published version)
You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. You may not use the material for commercial purposes. Exportado de SIDERAL (2021-09-02-09:54:57)
Permalink:
Visitas y descargas
Este artículo se encuentra en las siguientes colecciones:
Articles
Record created 2020-10-19, last modified 2021-09-02